Internal Medicine, Cardiovascular Disease · Bellingham, WA
NPI
1346246790
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
2979 Squalicum Pkwy, Suite 101
Bellingham, WA, 98225
Phone (360) 734-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
4,199 services
Medicare patients, 2024
2,192
Average age 77
Drug cost, 2024
$1.4M
4,764 prescriptions
Company payments, 2024
$17.12
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Spencer W Hinds was code 93010 (electrocardiogram), 1,364 times for 1,129 patients. In total Spencer W Hinds billed 4,199 services in 45 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,364 | 1,129 | $5.64 | $7,688 |
| 93306 Echocardiography (TTE/TEE) | Facility | 423 | 423 | $47.58 | $20K |
| 99214 Office E&M - Established | Facility | 374 | 337 | $64.55 | $24K |
| 93010 Electrocardiogram | Office | 340 | 329 | $5.11 | $1,736 |
| 93793 Care Management/Coordination | Office | 270 | 64 | $7.35 | $1,986 |
| 93018 Electrocardiogram | Facility | 145 | 145 | $10.08 | $1,462 |
| 93016 Electrocardiogram | Facility | 137 | 137 | $14.64 | $2,005 |
| 78452 Myocardial Perfusion Scan | Facility | 109 | 109 | $56.36 | $6,143 |
| 85610 Clinical Chemistry | Office | 81 | 18 | $4.20 | $340 |
| 93325 Echocardiography (TTE/TEE) | Facility | 78 | 77 | $2.24 | $174 |
| 93321 Echocardiography (TTE/TEE) | Facility | 78 | 77 | $5.15 | $402 |
| 93248 Electrocardiogram | Facility | 71 | 71 | $18.61 | $1,322 |
| 99233 Hospital E&M - Subsequent | Facility | 63 | 41 | $89.30 | $5,626 |
| 93005 Electrocardiogram | Office | 59 | 58 | $4.75 | $281 |
| 99215 Office E&M - Established | Facility | 55 | 49 | $100.40 | $5,522 |
By year: 2022 $153K for 4,479 services; 2023 $137K for 4,586 services; 2024 $113K for 4,199 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 81 | 18 | $4.20 | $340 |
Medicare prescription drug claims, 2024
In 2024, the drug Spencer W Hinds prescribed most often to Medicare patients was Metoprolol Succinate, with 532 prescriptions and refills. In total Spencer W Hinds wrote 4,764 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 532 | 1,419 | 189 | $8,511 |
| Eliquis Apixaban | 360 | 713 | 92 | $402K |
| Losartan Potassium Generic | 281 | 747 | 104 | $2,748 |
| Atorvastatin Calcium Generic | 266 | 713 | 88 | $2,515 |
| Spironolactone Generic | 259 | 587 | 82 | $1,579 |
| Lisinopril Generic | 177 | 459 | 56 | $1,242 |
| Rosuvastatin Calcium Generic | 171 | 450 | 64 | $1,455 |
| Metoprolol Tartrate Generic | 170 | 424 | 73 | $1,083 |
| Xarelto Rivaroxaban | 147 | 309 | 43 | $168K |
| Amlodipine Besylate Generic | 140 | 360 | 50 | $1,130 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 136 | 294 | 39 | $2,089 |
| Warfarin Sodium Generic | 133 | 369 | 48 | $1,651 |
| Jardiance Empagliflozin | 119 | 243 | 29 | $126K |
| Nitroglycerin Generic | 118 | 122 | 67 | $1,291 |
| Carvedilol Generic | 116 | 312 | 47 | $1,231 |
Brand drugs: 888 claims; generic drugs: 3,876 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Spencer W Hinds $17.12 ($17.12 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $17.12.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $17.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.